Smoking Nicotine and Heart Health
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.
These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.
In Brief
Most people associate secondhand smoke with lung disease. Far fewer realize it is also an important cause of cardiovascular disease. Even brief exposure affects blood vessels and blood clotting in ways that raise the risk of heart attack and stroke. Secondhand smoke — the mix that rises from a burning cigarette plus what the smoker breathes out — reaches a nonsmoker’s blood vessels directly, and its effects on the platelets and artery lining that trigger heart attacks are nearly as large as an active smoker’s, even though the nonsmoker breathes in only a small fraction of the dose.¹,² That is why it matters even at low levels, and why nonsmokers who live or work around smoke carry roughly a 25–30% higher risk of coronary heart disease and a 20–30% higher risk of stroke.⁵ This is not theoretical: secondhand smoke causes an estimated 34,000 heart-disease deaths and more than 8,000 stroke deaths a year among U.S. nonsmokers, and when communities went smoke-free, heart-attack hospitalizations fell.⁶,¹⁰ This article explains what secondhand smoke is, how it reaches the cardiovascular system at low doses, what the population evidence shows, who is most exposed — including children and people who already have heart disease — and why ventilation and “smoking sections” do not fix it. There is no risk-free level. The remedy that works is smoke-free air.¹
Breathing Someone Else’s Smoke Is a Cardiovascular Exposure
Article 1 showed that tobacco smoke injures the cardiovascular system of the person smoking. The same smoke, diluted in the air of a room, a car, or a home, reaches the blood vessels of everyone else there.
Secondhand smoke — also called environmental tobacco smoke or passive smoke — is not a single stream. It is a mix of two things: sidestream smoke, which rises from the smoldering tip of a cigarette between puffs, and the mainstream smoke the smoker breathes out.¹ Sidestream smoke is not a milder version of what the smoker inhales. Because the tip burns cooler between puffs, sidestream smoke forms under different conditions and carries high concentrations of many of the same toxic and cancer-causing compounds.¹ Once it is in the air, anyone nearby breathes it. (Residual tobacco contaminants left on surfaces and in dust — sometimes called “thirdhand smoke” — are a separate, still-emerging area of research and are not the focus here.)
Most people assume a diluted exposure means a proportionally smaller risk — that breathing a little of someone’s smoke is a little of the harm. For the cardiovascular system, that is not how it works. This is the second article in a ten-part series. Article 1 covered what smoking does to the smoker’s own heart and vessels. Here the question is what that same smoke does to the people who did not choose it.
A Large Cardiovascular Effect From a Small Exposure
The central finding about secondhand smoke is a mismatch between dose and effect. A nonsmoker who shares a home with a smoker breathes in a tiny fraction of the smoke the smoker does — on the order of a hundredth of the dose.² Yet the rise in cardiovascular risk is nowhere near a hundredth of a smoker’s.
A comprehensive review of the evidence found that secondhand smoke raises the risk of coronary heart disease by about 30%.² What makes this striking is that the effect is far larger than the dose alone would predict.² The reason is in the mechanisms. The acute effects of secondhand smoke on the cardiovascular system — on platelet activation, endothelial function, arterial stiffness, oxidative stress, inflammation, and heart rate variability — are, on average, 80% to 90% as large as the effects of long-term active smoking. Some appear after only minutes to hours of exposure.²
This needs to be stated precisely, because it is easy to misread. It does not mean that breathing secondhand smoke is as dangerous, overall, as smoking a pack a day. The lifetime coronary risk that secondhand smoke adds — roughly a quarter to a third above baseline — is smaller than an active smoker’s.⁴,⁵ What it means is narrower and still important: the specific mechanisms that trigger sudden cardiovascular events do not scale down in proportion to the dose. They switch on substantially at small exposures and change relatively little as exposure rises.
This is the same pattern from Article 1, where one cigarette a day carried roughly half the excess coronary risk of a full pack. The dose-response curve for the acute, event-triggering mechanisms is steep at the very bottom and flat higher up. Secondhand smoke sits at the bottom of that curve. The bottom of the curve is not a safe place to be.
How Secondhand Smoke Reaches the Blood Vessels of a Nonsmoker
The mechanisms are the ones from Article 1, now working in someone who is not smoking. Three of them dominate.
Endothelial dysfunction. The endothelium is the single-cell lining of every blood vessel. It makes nitric oxide, which keeps arteries relaxed and clot-resistant. Secondhand smoke impairs it, and quickly. In a study of healthy teenagers and young adults with no other risk factors, passive smoking was tied to reduced flow-mediated dilation — the artery’s ability to widen when blood flow increases — and the reduction tracked with the amount of exposure.³ These were young people whose only relevant exposure was other people’s smoke, and their arteries already showed the earliest measurable step of atherosclerosis.³
Platelet activation. Even brief exposure to secondhand smoke makes platelets — the cell fragments that start clots — stickier and more likely to clump.²,⁵ Because the clot that forms on a ruptured plaque is what causes most heart attacks, a shift toward easier clotting is a direct route from a smoky room to a cardiovascular event — especially in someone whose arteries already carry plaque.
Inflammation, oxidative stress, and autonomic change. Secondhand smoke raises markers of inflammation and oxidative stress and shifts heart rate variability, a measure of the autonomic nervous system’s balance.² In experimental exposures, it has also increased the size of the injury during an induced heart attack.² These are the same pathways by which active smoking damages the vasculature, reproduced at lower exposure.
The common thread is speed. Unlike the slow buildup of plaque over decades, several of these effects appear within minutes to hours, and they involve triggering events rather than only building disease.² That is why the guidance later emphasizes avoiding even brief exposure, and why it matters most for people who already have coronary disease.
These mechanisms reinforce one another. Endothelial dysfunction promotes inflammation. Inflammation accelerates atherosclerosis. Platelet activation makes it more likely that a plaque rupture becomes an acute heart attack or stroke. Secondhand smoke works on several of these pathways at once, not one in isolation. And although some of these effects appear within minutes or hours, repeated exposure lets the injury accumulate over years.
What the Population Studies Show
The mechanisms are matched by decades of population data. A meta-analysis of nonsmokers married to smokers found that regular exposure to a spouse’s smoke was tied to about a 25% higher risk of coronary heart disease.⁴ Larger reviews and the Surgeon General’s assessments put the increase in coronary heart disease risk at roughly 25–30%, and the increase in stroke risk at roughly 20–30%.⁵ On the combined mechanistic and population evidence, the Surgeon General concluded that the link between secondhand smoke and coronary heart disease is causal, and that secondhand smoke is a cause of stroke — not merely associated with them.⁵
A figure like “25–30%” needs a baseline to mean anything, and it cuts two ways. For one nonsmoker, a quarter-to-a-third increase above their own baseline is a real but modest absolute change. Across a population of tens of millions, it becomes a large number of events. In the United States, secondhand smoke is estimated to cause about 34,000 premature heart-disease deaths and more than 8,000 stroke deaths each year among nonsmokers.¹⁰ Worldwide, it caused an estimated 599,000 cardiovascular deaths in 2019 — nearly half of all deaths it caused that year — with ischemic heart disease the largest single category.⁹ These are people who never chose to smoke.
The table below collects the main figures in one place.
| What the evidence shows | Size of the effect |
| Coronary heart disease risk in exposed nonsmokers | About 25–30% higher⁵ |
| Stroke risk in exposed nonsmokers | About 20–30% higher⁵ |
| U.S. heart-disease deaths per year among nonsmokers | About 34,000¹⁰ |
| U.S. stroke deaths per year among nonsmokers | More than 8,000¹⁰ |
| Worldwide cardiovascular deaths in 2019 | About 599,000⁹ |
| Coronary admissions after comprehensive smoke-free laws | About 15% lower⁶ |
| Stroke admissions after comprehensive smoke-free laws | About 16% lower⁶ |
The Natural Experiment: Smoke-Free Laws and Heart Attacks
Some of the most convincing evidence comes not from following individuals but from watching whole communities when the exposure is removed. When cities and countries passed comprehensive smoke-free laws — banning smoking in workplaces, restaurants, and bars — researchers could compare hospital admissions before and after.
A meta-analysis of these natural experiments found that comprehensive smoke-free laws were followed by significantly lower hospitalizations: about 15% fewer admissions for coronary events and about 16% fewer for strokes, along with fewer respiratory admissions.⁶ The effect tracked with the strength of the law — more comprehensive laws produced larger drops — which is the dose-response pattern you expect from a real causal effect, not a coincidence.⁶ Reviewing this evidence, an expert committee concluded that smoke-free laws reduce acute coronary events.⁷
This matters for two reasons. First, it closes the loop: if removing secondhand smoke lowers heart attacks across a population, the exposure was causing heart attacks to begin with. Second, it shows the problem can be fixed. The same biology that makes secondhand smoke harmful also makes protection from it work fast — the acute mechanisms that switch on with exposure switch back off when it ends. Smoke-free policies are one of the clearest examples in medicine of a population-level intervention producing measurable reductions in acute cardiovascular events.
The People Most Exposed — and Most Vulnerable
Secondhand smoke exposure has dropped sharply in countries with strong tobacco control, but it has not disappeared, and it is not spread evenly. In the United States, exposure among nonsmokers fell from about 88% in the late 1980s to about 25% by 2013–2014 — but that remaining quarter is still roughly 58 million people.⁸ Exposure is much higher among children, non-Hispanic Black Americans, people living in poverty, people in rental housing, and — most of all — nonsmokers who live with someone who smokes indoors, among whom nearly three-quarters show biological evidence of exposure.⁸ Increasingly, secondhand smoke is concentrated among those with the least ability to avoid it.
A few groups deserve specific attention.
Children. For a cardiovascular series, the notable point is that the vascular effects start early: the study of impaired arterial function above was done in healthy teenagers and young adults, whose arteries already showed endothelial dysfunction from passive smoke.³ Secondhand smoke also causes sudden infant death syndrome and serious childhood respiratory illness.¹ Children rarely control the air they breathe, so the adults around them make the difference.
People who already have heart disease. This is the group for whom the acute mechanisms matter most. Someone with existing coronary disease has plaques that can rupture and arteries with little reserve, so the platelet activation and endothelial impairment triggered by even brief exposure carry more immediate danger. Public health guidance is explicit that people with heart disease are at especially high risk and should avoid it.⁵ The underlying disease is covered in the Coronary Artery Disease series.
During pregnancy. Exposure to secondhand smoke in pregnancy is linked to lower birth weight.¹ The cardiovascular considerations specific to pregnancy, including how early development shapes later risk, are covered in the Women and Cardiovascular Health series.
Partners and coworkers. The spousal studies that anchor much of the evidence describe exactly this — a nonsmoker who shares a home, or historically a workplace, with a smoker and builds up exposure over years.⁴ Smoke-free workplace laws exist largely because that exposure was shown to cause disease in people who were simply doing their jobs.
Common Beliefs vs What the Evidence Shows
Several widely held beliefs about secondhand smoke understate the cardiovascular risk or misjudge how to reduce it.
| Common Belief | What the Evidence Shows |
| “A little secondhand smoke won’t hurt anyone.” | The acute effects on platelets and the artery lining are nearly as large as active smoking’s and appear within minutes to hours; there is no risk-free level.¹,² |
| “Secondhand smoke is a lung problem; it doesn’t affect the heart.” | It has immediate effects on the heart and blood vessels and causes coronary heart disease and stroke in nonsmokers, raising each risk by roughly 20–30%.⁵ |
| “Opening a window, using a fan, or a ‘smoking section’ takes care of it.” | Ventilation and air cleaning cannot remove secondhand smoke exposure; only a smoke-free space does.¹ |
| “My smoking only affects me.” | The same smoke reaches everyone nearby; secondhand smoke causes an estimated 34,000 heart-disease deaths a year among U.S. nonsmokers, including children and partners.¹⁰ |
What This Means
The practical implications here are unusually clear, because the exposure is external — removable in a way many cardiovascular risks are not.
A smoke-free home and a smoke-free car are the highest-value steps. For most nonsmokers today, the home is the main remaining source of exposure, and for children it is nearly the only one they cannot escape.⁸ Making the home and car completely smoke-free — not a designated room, not “only near the window” — removes the largest controllable exposure. A car is an especially concentrated space; opening a window increases air exchange but does not remove the exposure for other occupants.¹
Ventilation and separation do not work. This is worth stating plainly, because it contradicts a common assumption and explains decades of ineffective “smoking sections.” Air cleaners, fans, open windows, and separate areas within a shared space reduce the smell but not the cardiovascular exposure. The Surgeon General concluded that separating smokers from nonsmokers in the same airspace, cleaning the air, and increasing ventilation all fail to protect nonsmokers; only eliminating indoor smoking does.¹
If you are the person who smokes, none of this is about blame. Wanting to protect your family and finding it hard to quit are not in conflict — nicotine dependence is a real physical condition, not a lack of care, and it is the subject of Article 3. Keeping all smoking outside the home and car is the single most protective step you can take for the people you live with right now. But it is not a substitute for quitting: continued smoking remains the biggest threat to your own heart. Quitting protects them and you at the same time, and the medications and methods that make it achievable are covered in Articles 5 and 6.
People with existing heart disease should treat brief exposure as something to avoid, not tolerate. Because the platelet and endothelial effects are immediate, a person with coronary disease has a concrete reason to leave a smoky environment rather than wait it out.⁵
The gains are real and shared. When a household becomes smoke-free, everyone in it benefits — including the smoker, and including children whose arteries are still developing — and the population evidence from smoke-free laws shows those gains are large enough to move hospitalization rates.⁶
When cardiovascular symptoms are an emergency. Because this article concerns heart attack and stroke — events that can happen in exposed nonsmokers — the warning signs are worth stating. Sudden chest pain, pressure, or tightness; pain spreading to the arm, jaw, or back; sudden shortness of breath; sudden weakness, numbness, difficulty speaking, or facial drooping; sudden vision loss; a sudden severe headache; or loss of consciousness or near-fainting can be emergency signs of a heart attack or stroke. Call emergency services immediately.
What This Means for You
- Make your home and car completely smoke-free. Not a designated room or an open window — those reduce the smell, not the cardiovascular exposure. Only a fully smoke-free space protects the people in it.¹
- There is no safe level. The mechanisms that trigger heart attacks switch on at very low doses, so even brief exposure counts.¹,²
- If you have heart disease, leave a smoky environment rather than wait it out. The platelet and endothelial effects are immediate.⁵
- If you smoke, keeping it outside protects your family now — and quitting protects everyone, including you.Nicotine dependence is real and treatable; Articles 3, 5, and 6 cover why it is hard and what works.
How Strong Is the Evidence?
Not all of the conclusions in this article rest on equally certain evidence, and knowing the difference is part of using it well. The table below summarizes how confident the current evidence is in each main conclusion.
| Conclusion | Strength of evidence |
| Secondhand smoke causes coronary heart disease and stroke in nonsmokers | Very high — Surgeon General causal conclusion⁵ |
| Its acute cardiovascular effects approach those of active smoking despite a far lower dose | High² |
| Smoke-free laws are followed by fewer heart-attack hospitalizations | High⁶,⁷ |
| Ventilation and “smoking sections” do not remove the cardiovascular exposure | High¹ |
| There is no risk-free level of secondhand smoke | High¹,² |
Clinical Bottom Line
Secondhand smoke is a real cardiovascular hazard, not a nuisance. It reaches a nonsmoker’s blood vessels directly, and because the mechanisms that trigger heart attacks — platelet activation and endothelial injury — switch on substantially at very low doses, brief exposure produces effects nearly as large as active smoking’s despite a fraction of the dose.¹,² Long-term exposure raises coronary heart disease and stroke risk by roughly 20–30%, a link the Surgeon General has judged causal, and in the United States alone it causes an estimated 34,000 heart-disease deaths and more than 8,000 stroke deaths a year among nonsmokers.⁵,¹⁰ The exposure is external and removable: ventilation and “smoking sections” do not work, but smoke-free homes, cars, and workplaces do — and communities that adopted smoke-free laws saw heart-attack hospitalizations fall.⁶ There is no risk-free level, so the goal is not less exposure but none.
What Comes Next
This article extended the biology of Article 1 to the people around the smoker, and showed that the cardiovascular harm of tobacco smoke does not stop at the smoker’s own body. Article 3 turns to a different question: why, given all of this, quitting is so hard. It looks at nicotine and the brain — how dependence forms, why cravings and relapses are physical events rather than moral ones, and why understanding that is the first step toward overcoming it.
Key Terms
Endothelium: The single-cell layer lining every blood vessel; produces nitric oxide, regulates vessel tone and clotting, and is impaired within minutes by secondhand smoke.
Environmental tobacco smoke: Another term for secondhand smoke — the tobacco smoke present in the air of a shared space.
Flow-mediated dilation: A test of how well an artery widens in response to increased blood flow; a measure of endothelial function, reduced in people exposed to secondhand smoke.
Ischemic heart disease: Heart disease caused by reduced blood flow through narrowed or blocked coronary arteries; used interchangeably here with coronary heart disease.
Mainstream smoke: The smoke a smoker inhales and then exhales; one of the two components of secondhand smoke.
Passive smoking: Involuntary inhalation of another person’s tobacco smoke; synonymous with secondhand smoke exposure.
Platelets: Cell fragments in the blood that initiate clotting; made stickier and more reactive by even brief secondhand smoke exposure.
Secondhand smoke: The mixture of sidestream smoke and exhaled mainstream smoke inhaled by nonsmokers sharing an air space with a smoker.
Sidestream smoke: Smoke rising from the smoldering tip of a cigarette between puffs; the larger component of secondhand smoke, containing high concentrations of many toxicants.
References
- U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2006. https://www.ncbi.nlm.nih.gov/books/NBK44324/
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation.2005;111(20):2684–2698. https://doi.org/10.1161/CIRCULATIONAHA.104.492215
- Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334(3):150–154. https://doi.org/10.1056/NEJM199601183340303
- He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease — a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340(12):920–926. https://doi.org/10.1056/NEJM199903253401204
- U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014. https://www.ncbi.nlm.nih.gov/books/NBK179276/
- Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation. 2012;126(18):2177–2183. https://doi.org/10.1161/CIRCULATIONAHA.112.121301
- Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence.Washington, DC: The National Academies Press; 2010. https://doi.org/10.17226/12649
- Tsai J, Homa DM, Gentzke AS, et al. Exposure to secondhand smoke among nonsmokers — United States, 1988–2014. MMWR Morb Mortal Wkly Rep. 2018;67(48):1342–1346. https://doi.org/10.15585/mmwr.mm6748a3
- Jiang H, Liu Z, Wei P, et al. Global, regional and national burdens of cardiovascular disease attributable to secondhand smoke from 1990–2019: an age-period-cohort analysis. Open Heart. 2025;12(1):e003079. https://doi.org/10.1136/openhrt-2024-003079
- Centers for Disease Control and Prevention. Health Problems Caused by Secondhand Smoke. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2025. https://www.cdc.gov/tobacco/secondhand-smoke/health.html
HeartBuddi® • Your heart. Own it.